Target intelligence / Profile preview

Local uterine immune cells

Molecular classification
Other
01

Overview

Local uterine immune cells represent a specialized population of leukocytes residing in the endometrium and decidua, primarily consisting of uterine natural killer (uNK) cells, macrophages, and T lymphocytes. These cells are fundamental to reproductive success, as they orchestrate the immunological environment necessary for embryo implantation and the remodeling of maternal spiral arteries to ensure adequate placental perfusion (Moffett & Colucci, 2014, Nature Reviews Immunology). Unlike peripheral immune cells, uterine immune cells exhibit unique phenotypes, such as the non-cytotoxic, pro-angiogenic nature of uNK cells during early pregnancy (Soveral et al., 2021, Frontiers in Immunology). Dysregulation or imbalance in these cell populations is strongly associated with reproductive disorders, including recurrent pregnancy loss, preeclampsia, and endometriosis (Tang et al., 2020, Journal of Reproductive Immunology). Pharmacological interventions targeting these cells often involve corticosteroids or hormonal therapies to modulate cytokine production and promote a tolerogenic state (Kwak-Kim et al., 2021, American Journal of Reproductive Immunology). Consequently, they are a focal point for therapeutic development in reproductive immunology and maternal-fetal medicine.

Other names
Uterine leukocytesDecidual immune cellsEndometrial immune cellsUterine mucosal immune cellsUterine natural killer cellsDecidual macrophages
02

Mechanism of action

Modulation of the local cytokine environment, suppression of cytotoxic activity in uterine natural killer cells, and promotion of regulatory T cell expansion to facilitate maternal-fetal tolerance (Kwak-Kim et al., 2021, American Journal of Reproductive Immunology).

03

Biological functions

Immune responseTissue remodelingAngiogenesisMaternal-fetal toleranceEmbryo implantation
04

Disease associations

InfertilityRecurrent pregnancy lossPreeclampsiaEndometriosisEndometrial cancer
05

Safety considerations

Systemic immunosuppressionIncreased risk of maternal infectionPotential disruption of physiological spiral artery remodelingOff-target effects on fetal development (Robertson et al., 2018, Nature Reviews Immunology)
06

Interacting drugs

Prednisolone

4 more in the full profile.

07

Biomarkers

CD56CD16CD14FoxP3Interferon-gammaInterleukin-10

Beyond the preview

Go deeper on Local uterine immune cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Local uterine immune cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call